Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis, Immunoglobulin Light-chain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT00898235
What this trial is testing

Collection of Samples and Clinical Data From Patients With Amyloid Diseases

Who this might be right for
Multiple Myeloma
Boston Medical Center 10,000
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Study completedNCT05968846
What this trial is testing

Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load

Who this might be right for
Systemic Amyloidosis
University of Tennessee Graduate School of Medicine 19
Testing effectiveness (Phase 2)Looking for participantsNCT06935162
What this trial is testing

Teclistamab in Previously Treated AL Amyloidosis

Who this might be right for
AL Amyloidosis
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03236792
What this trial is testing

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Icahn School of Medicine at Mount Sinai 28
Not applicableLooking for participantsNCT06205953
What this trial is testing

A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)

Who this might be right for
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 400
Early research (Phase 1)Ended earlyNCT01728259
What this trial is testing

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
Barbara Ann Karmanos Cancer Institute 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055724
What this trial is testing

Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis

Who this might be right for
AL Amyloidosis
Nanjing IASO Biotechnology Co., Ltd. 17
Not applicableStudy completedNCT04392960
What this trial is testing

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis

Who this might be right for
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableStudy completedNCT02111538
What this trial is testing

Body Composition in Systemic Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 127
Testing effectiveness (Phase 2)Study completedNCT00607581
What this trial is testing

Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 21
Not applicableStudy completedNCT00536601
What this trial is testing

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more
Roswell Park Cancer Institute 174
Not applicableStudy completedNCT04937777
What this trial is testing

A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 4,481
Testing effectiveness (Phase 2)UnknownNCT04316442
What this trial is testing

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Sorrento Therapeutics, Inc. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751471
What this trial is testing

BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)

Who this might be right for
AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Looking for participantsNCT07110844
What this trial is testing

Teclistamab-Daratumumab in AL Amyloidosis

Who this might be right for
Amyloid Light-chain Amyloidosis
Rajshekhar Chakraborty, MD 25
Testing effectiveness (Phase 2)Study completedNCT00520767
What this trial is testing

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

Who this might be right for
Primary Systemic AmyloidosisLight Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute 35
Early research (Phase 1)Study completedNCT01777243
What this trial is testing

Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis
GlaxoSmithKline 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04512235
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 281
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Next Page